These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8561713)

  • 1. Brachytherapy in oesophageal carcinoma.
    Leung JT; Kuan R
    Australas Radiol; 1995 Nov; 39(4):375-8. PubMed ID: 8561713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
    J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring relief of dysphagia in locally advanced esophageal carcinoma patients submitted to high-dose-rate brachytherapy.
    Grazziotin Reisner R; Reisner ML; Ferreira MA; Rosa AA; Veras IM; Carneiro TM; Wolff B; Viégas CM; Mendonça de Araújo CM; Marchiori E
    Brachytherapy; 2015; 14(1):84-90. PubMed ID: 25447340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.
    Sharma V; Mahantshetty U; Dinshaw KA; Deshpande R; Sharma S
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):310-5. PubMed ID: 11872275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
    Bhatt L; Tirmazy S; Sothi S
    Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliation of malignant dysphagia from oesophageal cancer. Rotterdam Oesophageal Tumor Study Group.
    Siersema PD; Dees J; van Blankenstein M
    Scand J Gastroenterol Suppl; 1998; 225():75-84. PubMed ID: 9515757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose rate brachytherapy for the palliation of malignant dysphagia.
    Homs MY; Eijkenboom WM; Coen VL; Haringsma J; van Blankenstein M; Kuipers EJ; Siersema PD
    Radiother Oncol; 2003 Mar; 66(3):327-32. PubMed ID: 12742273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer.
    Homs MY; Steyerberg EW; Eijkenboom WM; Siersema PD;
    Brachytherapy; 2006; 5(1):41-8. PubMed ID: 16563996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study.
    Spencer GM; Thorpe SM; Blackman GM; Solano J; Tobias JS; Lovat LB; Bown SG
    Gut; 2002 Feb; 50(2):224-7. PubMed ID: 11788564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
    Sur RK; Donde B; Levin VC; Mannell A
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brachytherapy in the Palliation of Oesophageal Cancer: Effective but Impractical?
    Sinha S; Varagunam M; Park MH; Maynard ND; Trudgill N; Crosby T; Cromwell DA
    Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):e87-e93. PubMed ID: 30982667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliation of carcinoma of the oesophagus with brachytherapy and the Didcott dilator.
    Sur RK; Didcott CC; Levin CV; Kulhavy M; Donde B; Schafer M; Gavenescu J
    Ann R Coll Surg Engl; 1996 Mar; 78(2):124-8. PubMed ID: 8678445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavitary radiation in the treatment of advanced esophageal carcinoma: a comparison of high dose rate vs. low dose rate brachytherapy.
    Harvey JC; Fleischman EH; Bellotti JE; Kagan AR
    J Surg Oncol; 1993 Feb; 52(2):101-4. PubMed ID: 7682263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brachytherapy for oesophageal cancer].
    Wong S; Hennequin C; Quero L
    Cancer Radiother; 2013 Apr; 17(2):159-61. PubMed ID: 23603254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancer.
    Harms W; Krempien R; Grehn C; Berns C; Hensley FW; Debus J
    Br J Radiol; 2005 Mar; 78(927):236-41. PubMed ID: 15730988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of laser treatment and intraluminal radiotherapy for malignant dysphagia.
    Shmueli E; Srivastava E; Dawes PJ; Clague M; Matthewson K; Record CO
    Gut; 1996 Jun; 38(6):803-5. PubMed ID: 8984013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined external beam and low dose rate intraluminal radiotherapy in oesophageal cancer.
    Caspers RJ; Zwinderman AH; Griffioen G; Welvaart K; Sewsingh EN; Davelaar J; Leer JW
    Radiother Oncol; 1993 Apr; 27(1):7-12. PubMed ID: 7687066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single session of intraluminal brachytherapy in palliation of oesophageal cancer.
    Jager J; Langendijk H; Pannebakker M; Rijken J; de Jong J
    Radiother Oncol; 1995 Dec; 37(3):237-40. PubMed ID: 8746593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.